Author

Sourav Ghorai

Scripps Research InstituteORCID 0000-0001-8093-5655Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1

Frequent Co-Authors

Alireza Rahimi· 2 shared Amal Gebara-LambiD· 2 shared Anil K. Sen GuptaiD· 2 shared Arnab K. ChatterjeeiD· 2 shared Ashley K. Woods· 2 shared Case W. McNamaraiD· 2 shared Frank O. WeissiD· 2 shared Gennadii A. GrabovyiiD· 2 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Alireza Rahimi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintOct 1, 2026

Pan-Coronavirus Protease Engagement and Differentiated Pharmacology of Antiviral Candidate CMX990

N. G. R. Dayan Elshan, Karen C. Wolff, Laura Riva…·Arnab K. Chatterjee

This study evaluates CMX990, a coronavirus Mpro inhibitor, showing broad antiviral activity against multiple coronaviruses and superior pharmacologic properties compared to existing inhibitors.

DOI 10.64898/2026.09.29.755428

humanexperimental assay

𝕏 PostBluesky

Pharmacology & ToxicologyVirusesPeer-reviewedJul 26, 2026

Orally Bioavailable SARS-CoV-2 Protease Inhibitors Bearing a Hydroxymethyl Ketone Warhead

N. G. R. Dayan Elshan, Karen C. Wolff, Frank O. Weiss…·Arnab K. Chatterjee

This paper describes the development of orally bioavailable SARS-CoV-2 protease inhibitors with a hydroxymethyl ketone warhead, showing improved potency and bioavailability compared to previous compounds.

1 citationtop 5%

experimental assaydrug response / drug discovery

𝕏 PostBluesky